Mirage FX
by Resmed, Ltd.
510(k) K102746
Mirage FX is a medical device (FDA Class II; FDA product code BZD, Ventilator, Non-Continuous (Respirator)) made by Resmed, Ltd., cleared under FDA 510(k) K102746 on 28 Dec 2010, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK102746 | Date28 Dec 2010 | StatusActive |
Official records
- FDA 510(k) database K102746
From the FDA record
- Received by the FDA
- 23 Sep 2010
- FDA decision
- 28 Dec 2010 (Substantially Equivalent)
- FDA review time
- 96 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- BZD
- Device class
- Class II
- Regulation
- 21 CFR Part 868.5905
- Advisory committee
- Anesthesiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code BZD (Ventilator, Non-Continuous (Respirator)).
- BIRD NIGHTBIRD NASAL CPAP SYSTEM by Bird Products Corp.
- IMASK TM by Vital Signs, Inc.
- INFANT NASAL CANNULAE ASSEMBLY by Ackrad Laboratories
- DreamWear Full 1133406 by Respironics Inc.
- WiZARD 310/320 Series CPAP Mask by Apex Medical Corp.
- SLEEPAP by Medical Industries America, Inc.
- EASYFIT SILKGEL NASAL MASK by Weinmann Gerate Fur Medizin GmbH + Co. KG
- CPAP HUMIDIFIER, MODEL HC238JHU by FISHER & PAYKEL HEALTHCARE, INC.
- GOLIFE NASAL MASK by Respironics, Inc.
- ARGYLE CPAP NASAL CANNULA by Sherwood Medical Co.